Home / 2021 (Page 100)

The primary analysis of AstraZeneca/Oxford’s vaccine is likely to put pressure on other companies to demonstrate reductions in transmission as soon as possible, says GlobalData, a leading data, and analytics company.   Arafa Salam, Ph.D., Infectious Diseases Analyst at GlobalData, comments: “While the efficacy profile of Pfizer/BioNtech

READ MORE
Best Shop Best Shop Best Shop Best Shop Best Shop Best Shop Best Shop